Emicizumab treatment and monitoring in a paediatric cohort: real‐world data von Barg, Assaf A., Livnat, Tami, Budnik, Ivan, Avishai, Einat, Brutman‐Barazani, Tami, Tamarin, Ilia, Bashari, Dalia, Misgav, Mudi, Kenet, Gili

Volltext

Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring von Barg, Assaf A., Budnik, Ivan, Avishai, Einat, Brutman‐Barazani, Tami, Bashari, Dalia, Misgav, Mudi, Lubetsky, Aaron, Kuperman, Amir A., Livnat, Tami, Kenet, Gili

Volltext

Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real‐world data von Misgav, Mudi, Brutman‐Barazani, Tami, Budnik, Ivan, Avishai, Einat, Schapiro, Jonathan, Bashari, Dalia, Barg, Assaf A., Lubetsky, Aaron, Livnat, Tami, Kenet, Gili

Volltext

Application of the PECARN head trauma rule to patients with haemophilia in the paediatric emergency department: A 15‐year retrospective study von Koppel, Jordanna H., Levy‐Mendelovich, Sarina, Barg, Assaf A., Brutman Barazani, Tami, Baruch, Shoham, Feldman, Oren

Volltext

Pediatric splenic infarction: Assessment of associated clinical conditions and outcome von Grishin, Evgeny, Soudack, Michalle, Levy‐Mendelovich, Sarina, Bezalel, Yael, Lubetsky, Aharon, Cohen, Omri, Brutman‐Barazani, Tami, Efros, Orly, Kenet, Gili, Barg, Assaf A.

Volltext

Emicizumab prophylaxis in infants: Single‐centre experience von Levy‐Mendelovich, Sarina, Greenberg‐kushnir, Noa, Budnik, Ivan, Barg, Assaf Arie, Cohen, Omri, Avishai, Einat, Barazani‐Brutman, Tami, Livnat, Tami, Kenet, Gili

Volltext

Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin‐induced thrombocytopenia von Cohen, Omri, Lange, Kfir, Budnik, Ivan, Tamarin, Ilia, Brutman‐Barazani, Tami, Barg, Assaf Arie, Rosenberg, Nurit, Lubetsky, Aharon, Kenet, Gili, Levy‐Mendelovich, Sarina

Volltext

Bleeding phenotype and hemostatic evaluation by thrombin generation in children with Noonan syndrome: A prospective study von Barg, Assaf A., Yeshayahu, Yonatan, Avishai, Einat, Budnik, Ivan, Cohen, Omri, Brutman‐Barazani, Tami, Dardik, Rima, Raas‐Rothschild, Annick, Levy‐Mendelovich, Sarina, Livnat, Tami, Pinhas‐Hamiel, Orit, Kenet, Gili

Volltext

Pediatric severe factor XI deficiency: A multicenter study von Barg, Assaf Arie, Levy‐Mendelovich, Sarina, Budnik, Ivan, Mandel‐Shorer, Noa, Dardik, Rima, Avishai, Einat, Brutman‐Barazani, Tami, Ifrah, Aviya Dvir, Oren‐Malek, Liat, Yacobovich, Joanne, Gilad, Oded, Nakav, Sigal, Fruchtman, Yariv, Revel‐Vilk, Shoshana, Miskin, Hagit, Kenet, Gili

Volltext

A Novel Murine Model Enabling rAAV8-PC Gene Therapy for Severe Protein C Deficiency von Levy-Mendelovich, Sarina, Avishai, Einat, Samelson-Jones, Benjamin J, Dardik, Rima, Brutman-Barazani, Tami, Nisgav, Yael, Livnat, Tami, Kenet, Gili

Volltext

Recognising the importance of the research nurse and study coordinators in enhancing retention of people with haemophilia in clinical trials von Khair, Kate, Thykjaer, Hanne, Barazani-Brutman, Tami, Bellm, Kelly, Benjamin, Christopher, Wakefield, Cindy, Williams, Nicola, Wongwerawattanakoon, Pakawan, Zhong, Huiqun, Mulders, Greta

Volltext

Subcutaneous Injection of Tranexamic Acid to Reduce Bleeding During Dermatologic Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial von Zilinsky, Isaac, Barazani, Tami Brutman, Visentin, Denis, Ahuja, Kiran, Martinowitz, Uriel, Haik, Josef

Volltext

rAAV8-PC Gene Therapy for Severe Protein C Deficiency Using a Novel Murine Model von Levy-Mendelovich, Sarina, Avishai, Einat, Samelson-Jones, Ben J, Dardik, Rima, barazani-Brutman, Tami, Nisgav, Yael, Livnat, Tami, Kenet, Gili

Volltext

Prospective Controlled Monitoring of Hemlibra Prophylaxis Initiation in a Large Cohort of Hemophilia a Patients- Real World Data von Barg, Assaf Arie, Livnat, Tami, Brutman-Barazani, Tami, Rosenberg, Nurit, Budnik, Ivan, Kenet, Gili

Volltext

Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study von Barg, Assaf A., Brutman-Barazani, Tami, Avishai, Einat, Budnik, Ivan, Cohen, Omri, Dardik, Rima, Levy-Mendelovich, Sarina, Livnat, Tami, Kenet, Gili

Volltext

Allergy and inhibitors in hemophilia - a rare complication with potential novel solutions von Levy-Mendelovich, Sarina, Livnat, Tami, Barg, Assaf Arie, Kidon, Mona, Brutman-Barazani, Tami, Kenet, Gili

Volltext

The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand Disease von Barg, Assaf Arie, Kenet, Gili, Livnat, Tami, Avishai, Einat, Budnik, Ivan, Brutman-Barazani, Tami, Tamarin, Ilia, Lubetsky, Aharon, Bashari, Dalia, Dardik, Rima, Lalezari, Shadan, Misgav, Mudi

Volltext

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab von Levy-Mendelovich, Sarina, Brutman-Barazani, Tami, Budnik, Ivan, Avishai, Einat, Barg, Assaf A., Levy, Tamara, Misgav, Mudi, Livnat, Tami, Kenet, Gili

Volltext

Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients von Cohen, Omri, Landau, Nitsan, Avisahai, Einat, Brutman-Barazani, Tami, Budnik, Ivan, Livnat, Tami, Asraf, Keren, Doolman, Ram, Levy-Mendelovich, Sarina, Efros, Orly, Manor, Uri, Meltzer, Eyal, Segal, Gad, Rahav, Galia, Kenet, Gili

Volltext

Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes von Levy-Mendelovich, Sarina, Atia, Nitzan, Budnik, Ivan, Barg, Assaf Arie, Avishai, Einat, Cohen, Omri, Brutman-Barazani, Tami, Livnat, Tami, Kenet, Gili

Volltext